لا تُقدم XM خدماتها لمواطني الولايات المتحدة الأمريكية.
G
G

Grifols


أخبار

Grifols rises as US FDA approves immune disorder drug

BUZZ-Grifols rises as US FDA approves immune disorder drug ** U.S.-listed shares of Spain-based drug developer Grifols SA GRLS.MC , GRFS.O rise 1.4% to $7.1 premarket ** Co says the US Food and Drug Administration has approved its drug to treat primary immunodeficiency disorder (PID) ** PID refers to a large group of disorders that result from defects in immune system development and/or function ** The drug, Yimmugo, is a ready-to-use solution of the antibody immunoglobulin G for intravenous adm
G

Grifols Unit Gets FDA Approval For Yimmugo Immunoglobulin To Treat Primary Immunodeficiencies

BRIEF-Grifols Unit Gets FDA Approval For Yimmugo Immunoglobulin To Treat Primary Immunodeficiencies June 17 (Reuters) - Grifols SA GRLS.MC : UNIT BIOTEST RECEIVES U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL FOR YIMMUGO IMMUNOGLOBULIN FOR TREATMENT OF PRIMARY IMMUNODEFICIENCIES Source text: https://tinyurl.com/4sd43tb7 Further company coverage:
G

Solaria shares jump on report of takeover interest

UPDATE 1-Solaria shares jump on report of takeover interest Adds Solaria declining to comment, updates share price June 14 (Reuters) - Shares in Spain's Solaria SLRS.MC jumped by as much as 10% on Friday after a Bloomberg report saying that the solar developer had received unsolicited takeover approaches. Solaria declined to comment. At 2 :12 p.m. ( 1212 GMT) the shares were trading 8.04 % higher on the day at 12.36 euros in Madrid, giving it a market value of over 1.5 billion euros.
G
S

Solaria shares jump on report of takeover interest

Solaria shares jump on report of takeover interest June 14 (Reuters) - Shares in Spain's Solaria SLRS.MC jumped by as much as 10% on Friday after a Bloomberg report saying that the solar developer had received unsolicited takeover approaches. At 1:16 p.m. (1116 GMT) the shares were trading 7.8% higher on the day at 12.33 euros in Madrid, giving it a market value of around 1.5 billion euros.
G
S

Spanish stocks - Factors to watch on June 5

Spanish stocks - Factors to watch on June 5 June 5 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Wednesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: INDITEX ITX.MC Zara owner Inditex's ITX.MC sales rose 7% in the first quarter of its fiscal year, it said on Wednesday, in line with analysts' expectations.
G
I
B
S

Grifols Closes Private Placement Of Additional 7.5% Notes Due 2030

BRIEF-Grifols Closes Private Placement Of Additional 7.5% Notes Due 2030 June 4 (Reuters) - Grifols SA GRLS.MC : SUCCESSFUL CLOSING OF PRIVATE PLACEMENT OF ADDITIONAL 7.5% SENIOR SECURED NOTES DUE 2030 FOR AMOUNT OF EUR 300 MILLION Source text for Eikon: ID:nCNM9JlDL2 Further company coverage: GRLS.MC (Gdansk Newsroom)
G

Grifols Board Members Victor Grifols Deu And Raimon Grifols Roura No Longer Hold "Executive Directors" Category

BRIEF-Grifols Board Members Victor Grifols Deu And Raimon Grifols Roura No Longer Hold "Executive Directors" Category May 31 (Reuters) - Grifols SA GRLS.MC : BOARD MEMBERS VICTOR GRIFOLS DEU AND RAIMON GRIFOLS ROURA NO LONGER HOLD CATEGORY OF "EXECUTIVE DIRECTORS" AS FROM 1 JUNE 2024 THEY HOLD CATEGORY OF "PROPRIETARY DIRECTORS" Source text for Eik
G

Solaria sees higher energy prices later this year, shares rise

UPDATE 2-Solaria sees higher energy prices later this year, shares rise Recasts with energy prices expectations, updates share moves, adds context and energy production By Matteo Allievi May 27 (Reuters) - Spanish solar panel maker Solaria SLRS.MC said on Monday it expected energy prices to recover over the year, which would help the firm reach its 2024 profitability target.
G
S

Grifols up after it swings to Q1 profit, 2024 outlook on track

BUZZ-Grifols up after it swings to Q1 profit, 2024 outlook on track ** Shares in Grifols GRLS.MC rise around 3.5% after the Spanish drugmaker swung to a Q1 net profit, reiterated 2024 guidance and said improving FCF and reducing debt are its top priorities ** Morningstar says it sees some "encouraging" signs for Grifols to return to positive FCF from the start of Q2 ** Grifols posted on Tuesday a negative Q1 FCF of 253 million euros ($274 million), vs negative 109 million euros a year earlier **
G

Spanish stocks - Factors to watch on May 15

Spanish stocks - Factors to watch on May 15 May 15 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Wednesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: AENA AENA.MC The European Investment Bank said on Tuesday it signed a 160 million euro loan with Aena to upgrade Palma de Mallorca airport's passenger terminal.
A
A
G
R
T
B
S

Grifols swings to profit, says debt reduction on track

UPDATE 2-Grifols swings to profit, says debt reduction on track Adds comments on operations in paragraph 4, free cash flow details in paragraphs 6-8, response to short-seller allegations on paragraphs 10-11 By Joan Faus BARCELONA, May 14 (Reuters) - Spanish drugmaker Grifols GRLS.MC swung to a first-quarter net profit of 21 million euros ($23 million) from a year-ago loss, and said on Tuesday it was on track to meet its 2024 outlook, including cutting debt .
G

Grifols Chairman Says Can Confirm Shanghai Raas Transaction Will Close In June

BRIEF-Grifols Chairman Says Can Confirm Shanghai Raas Transaction Will Close In June May 14 (Reuters) - Grifols SA GRLS.MC Chairman Thomas Glanzmann tells analysts call: CAN CONFIRM SHANGHAI RAAS TRANSACTION WILL CLOSE IN JUNE Further company coverage: GRLS.MC Reporting by Joan Faus
G

Grifols' CFO Alfredo Arroyo Will Leave Company Next Year

BRIEF-Grifols' CFO Alfredo Arroyo Will Leave Company Next Year May 14 (Reuters) - Grifols SA GRLS.MC Chairman Thomas Glanzmann tells analysts call: CFO ALFREDO ARROYO WILL LEAVE COMPANY NEXT YEAR Further company coverage: GRLS.MC Reporting by Joan Faus
G

Grifols Q1 Leverage Ratio As Per EBITDA As Per P&L And Net Debt As Per BS At 7.9x

BRIEF-Grifols Q1 Leverage Ratio As Per EBITDA As Per P&L And Net Debt As Per BS At 7.9x May 14 (Reuters) - Grifols SA GRLS.MC : Q1 LEVERAGE RATIO, AS PER CONSOLIDATED EBITDA AS PER PROFIT AND LOSS AND NET DEBT AS PER BALANCE SHEET, STOOD AT 7.9X (8.4X BY END OF 2023) Source text: https://tinyurl.com/bn6az2mb Further company coverage: GRLS.MC (Gdans
G

Grifols On Track To Meet FY 2024 Guidance

BRIEF-Grifols On Track To Meet FY 2024 Guidance May 14 (Reuters) - Grifols SA GRLS.MC : ON TRACK TO FY 2024 GUIDANCE Q1 NET REVENUES 1.63 BILLION EUROS VERSUS 1.56 BILLION EUROS YEAR AGO Q1 RESEARCH AND DEVELOPMENT NEGATIVE NET INVESTMENT 90.5 MILLION EUROS VERSUS NEGATIVE 104.7 MILLION EUROS YEAR AGO CURRENTLY WORKING TO IMPROVE FCF GUIDANCE IN LI
G

Spain's Grifols swings to first-quarter profit of 21 mln euros

Spain's Grifols swings to first-quarter profit of 21 mln euros BARCELONA, May 14 (Reuters) - Spanish drug maker Grifols GRLS.MC , battling a plunge in its share price this year, on Tuesday posted a first-quarter net profit of 21 million euros ($22.71 million), in a swing from a year-ago loss as revenues rose 4.1%. Since early January, short-sheller fund Gotham City Research has released several reports accusing Grifols of overstating earnings and understating debt.
G

Grifols shares fall after new Gotham City Research report

UPDATE 2-Grifols shares fall after new Gotham City Research report Updates share reaction, adds background in paragraph 10 BARCELONA, May 14 (Reuters) - Grifols GRLS.MC shares were down 2.7% on Tuesday morning following the publication of a new report by short-seller Gotham City Research which again questioned the Spanish drugmaker's "commitment to transparency, integrity and ethical conduct".
G

Grifols falls after Gotham City issues new report

BUZZ-Grifols falls after Gotham City issues new report ** Shares of Grifols GRLS.MC are down 3%, paring losses after falling as much as 5.8%, after Gotham City Research issued a new report on Tuesday questioning Grifols' "commitment to transparency, integrity and ethical conduct" ** Grifols didn't immediately respond to a request to comment ** Sinc
G
S

Grifols shares fall after new Gotham City Research report

Grifols shares fall after new Gotham City Research report MADRID, May 14 (Reuters) - Grifols GRLS.MC shares were down 3.9% on Tuesday morning following the publication of a new report by short-seller Gotham City Research which again questioned the Spanish drugmaker's "commitment to transparency, integrity and ethical conduct". A spokesperson for the Barcelona-based company did not immediately respond to a request for comment.
G

Carlsberg, Danske Bank, Teleperformance

EUROPE RESEARCH ROUNDUP- Carlsberg, Danske Bank, Teleperformance May 10 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Carlsberg, Danske Bank and Teleperformance, on Friday. HIGHLIGHTS * Carlsberg A/S CARLB.CO : HSBC raises target price to DKK 1040 from DKK 1030 * Danske Bank DANSKE.CO : HSBC cuts target price to DKK 231 from DKK 238 * Hermes HRMS.PA : Jefferies initiates coverage with buy rating; price target EUR 2,650 * Rathbone
3
A
A
A
B
B
B
B
B
C
C
C
C
D
F
G
G
H
I
K
L
M
P
P
R
S
S
S
T
V
W
Z
A
D
S
S



الشروط

الأصول الشائعة

إخلاء المسؤولية: تتيح كيانات XM Group خدمة تنفيذية فقط والدخول إلى منصة تداولنا عبر الإنترنت، مما يسمح للشخص بمشاهدة و/أو استخدام المحتوى المتاح على موقع الويب أو عن طريقه، وهذا المحتوى لا يراد به التغيير أو التوسع عن ذلك. يخضع هذا الدخول والاستخدام دائماً لما يلي: (1) الشروط والأحكام؛ (2) تحذيرات المخاطر؛ (3) إخلاء المسؤولية الكامل. لذلك يُقدم هذا المحتوى على أنه ليس أكثر من معلومات عامة. تحديداً، يرجى الانتباه إلى أن المحتوى المتاح على منصة تداولنا عبر الإنترنت ليس طلباً أو عرضاً لدخول أي معاملات في الأسواق المالية. التداول في أي سوق مالي به مخاطرة عالية برأس مالك.

جميع المواد المنشورة على منصة تداولنا مخصصة للأغراض التعليمية/المعلوماتية فقط ولا تحتوي - ولا ينبغي اعتبار أنها تحتوي - على نصائح أو توصيات مالية أو ضريبية أو تجارية، أو سجلاً لأسعار تداولنا، أو عرضاً أو طلباً لأي معاملة في أي صكوك مالية أو عروض ترويجية مالية لا داعي لها.

أي محتوى تابع للغير بالإضافة إلى المحتوى الذي أعدته XM، مثل الآراء، والأخبار، والأبحاث، والتحليلات والأسعار وغيرها من المعلومات أو روابط مواقع تابعة للغير وواردة في هذا الموقع تُقدم لك "كما هي"، كتعليق عام على السوق ولا تعتبر نصيحة استثمارية. يجب ألا يُفسر أي محتوى على أنه بحث استثماري، وأن تلاحظ وتقبل أن المحتوى غير مُعدٍ وفقاً للمتطلبات القانونية المصممة لتعزيز استقلالية البحث الاستثماري، وبالتالي، فهو بمثابة تواصل تسويقي بموجب القوانين واللوائح ذات الصلة. فضلاً تأكد من أنك قد قرأت وفهمت الإخطار بالبحوث الاستثمارية غير المستقلة والتحذير من مخاطر المعلومات السابقة، والذي يمكنك الاطلاع عليه هنا.

تحذير المخاطر: رأس مالك في خطر. المنتجات التي تستخدم الرافعة قد لا تكون مناسبة للجميع. يرجى الاطلاع على تنبيه المخاطر.